Amgen and Arrakis Aim to Destroy Disease with Targeted RNA Degraders
Amgen will partner with Arrakis Therapeutics for an innovative collaboration to research and develop RNA degrader therapeutics.
Source: biospace.com
Stay updated with breaking news from Induced Proximity Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amgen will partner with Arrakis Therapeutics for an innovative collaboration to research and develop RNA degrader therapeutics.
THOUSAND OAKS, Calif. and WALTHAM, Mass., Jan. 11, 2022 /PRNewswire/ -- Amgen and Arrakis Therapeutics today announced a research collaboration focused on the discovery and... | January 11, 2022